iSTAR Medical SA, headquartered in Wavre, Belgium, is a clinical stage medical technology company focused on the development of novel ophthalmic implants for glaucoma.
Glaucoma is the second leading cause of adult blindness globally. Micro-invasive glaucoma surgery (MIGS) is the most promising and fastest-growing therapeutic option in the treatment of glaucoma. iSTAR has exclusive rights to the STAR material from the University of Washington in Seattle (USA) for ophthalmic use. This provides the foundation for the development of MINIject, which is designed to be a best in class MIGS device. The fast-growing glaucoma drainage device market is expected to reach $1bn worldwide by 2020.
iSTAR Medical’s management team and board have a successful track record in end-to-end product development, with proven clinical, regulatory and market access capabilities. The company is backed by specialised institutional and private investors.
Location: Belgium, Walloon Brabant, Wavre
Employees: 11-50
Total raised: $61.02M
Founded date: 2010
Investors 9
Funding Rounds 3
| Date | Series | Amount | Investors |
| 05.09.2019 | Series C | $44.23M | - |
| 12.04.2016 | Series B | $11.39M | - |
| 21.11.2013 | Series A | $5.4M | - |
Mentions in press and media 18
| Date | Title | Description | Source |
| 15.07.2021 | iSTAR Medical receives U.S. FDA approval to start pivotal tr... | prnewswire... | |
| 15.07.2021 | iSTAR Medical receives U.S. FDA approval to start pivotal tr... | prnewswire... | |
| 15.07.2021 | iSTAR Medical receives U.S. FDA approval to start pivotal tr... | WAVRE, Belgium, July 15, 2021 /PRNewswire/ -- iSTAR Medical, a med-tech company developing minimally... | en.prnasia... |
| 15.07.2021 | iSTAR Medical receives US FDA approval to start pivotal tria... | Wavre, Belgium: 15 July 2021 – iSTAR Medical, a med-tech company developing minimally-invasive impla... | capricorn.... |
| 16.11.2020 | iSTAR Medical’s glaucoma device MINIject shows positive one-... | Wavre, Belgium: 16 November 2020 – iSTAR Medical, a medtech company developing minimally invasive op... | capricorn.... |
| 29.09.2020 | Positive outcomes for iSTAR Medical’s MIGS MINIject shown in... | Pooled data confirm excellent safety and efficacy profile with very low rate of reintervention | capricorn.... |
| 29.04.2020 | iSTAR Medical announces outstanding results with MIGS implan... | Two-year final results from STAR-I trial and initial data from STAR-II European trial tout MINIjectT... | capricorn.... |
| 06.12.2019 | Best of 2019: 10 Belgium tech startups that scored maximum f... | Entrepreneurs in Belgium eyeing to raise funds might have an easier time right now to grow their ric... | siliconcan... |
| 05.09.2019 | iSTAR Medical Raises €40M in Series C Financing | iSTAR Medical SA, a Wavre, Belgium-based medical device company developing novel ophthalmic implants... | finsmes.co... |
| 05.09.2019 | iSTAR Medical announces € 40 million Series C financing | To accelerate development and commercialisation of innovative Glaucoma MIGS device, MINIjectTM | capricorn.... |
Show more